E.l.f. Beauty posts earnings beat, raises full-year guidance
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Corporate DEI index sees 65% drop in participation from Fortune 500 companies
Terrell Owens calls Hall of Fame process 'broken' after Belichick, Kraft snubs
Yum Brands posts mixed quarter, Taco Bell shines
Streaming-only Super Bowl ads give small brands a shot at the big game
Chipotle stock sinks as restaurant chain reports falling traffic, weak guidance
A surprising share of homeowners have high mortgage rates. Here's the breakdown
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook
PepsiCo's drink sales are improving, and it's planning to cut snack prices
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms
Who is Josh D'Amaro, Disney's next CEO?
Patriots owner Robert Kraft responds to Hall of Fame controversy
December CRE deal volume sinks further, but office is a surprising bright spot
AI will supercharge sports team valuations, says Arctos Partners’ Charles
Disney names parks boss Josh D’Amaro as its next CEO to succeed Bob Iger, effective March 18
Camden CEO on why he’s seeing ‘huge’ investor demand for apartment buildings
Big Food gets leaner with divestitures and breakups as consumers turn away from packaged snacks
Here are the retailers with the most store openings and closures planned for 2026
New York AG issues warning around prediction markets ahead of Super Bowl
Disney supercharged its parks. The booming division still has room to run
GameStop's Ryan Cohen eyes 'very big' consumer megadeal that could increase company's value tenfold
Disney signals its next CEO will take over a company with strong momentum
Disney beats Wall Street expectations propelled by theme parks and streaming
'Melania' earns a surprising $7 million, the highest opening for a nonmusic documentary in a decade
Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launch
American Express, credit card provider to the wealthy, wants even more high spenders
Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections